Why the study?
To examine and compare various variables, particularly the monocyte to high-density lipoprotein cholesterol ratio, between women with polycystic ovary syndrome and healthy controls.
Population
259 women aged 18-38, including 194 with PCOS and 65 without PCOS
Comparison
Women with PCOS vs healthy controls
Design
Retrospective single-centre database study
Authors
Loading...
Similar MHR in PCOS and controls; leaves open its inflammatory role, requiring prospective studies before any clinical consideration.
Contrary to previous studies, the monocyte/HDL ratio was not significantly altered in women with PCOS and cannot be reliably used to quantify inflammation or lipid profile changes in this population.
GÜRBÜZ et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: